Companies / Other
Regeneron Pharmaceuticals
A biotechnology company that won the 23andMe auction and then served as backup bidder. Recorded here: 2 public prices.
regeneron.comLatest record 13 Jun 2025
Public prices involving Regeneron Pharmaceuticals
- Substantially all assets of 23andMe Holding Co. excluding the Lemonaid telehealth business, Regeneron Pharmaceuticals' final backup bid after TTAM's $305 million won the 13 June 2025 final round
The notice sets out TTAM's winning $305 million beside the backup. Regeneron's agreement was unchanged except that its price fell from $256 million to $151 million because it now served as backup bidder, and the assets exclude the Lemonaid telehealth business, which explains part of the gap.
Court record, In re 23andMe Holding Co., No. 25-40976 (Bankr. E.D. Mo.), ECF 739, Notice of Winning Bidder (13 Jun 2025)
$151 million, plus payment of cure amounts and assumption of certain liabilitiesper backup bid for substantially all assets of one company (whole-business bundle)
- Substantially all assets of 23andMe Holding Co. (about 13 million customers' genetic and other personal data, laboratory, brand), Regeneron Pharmaceuticals' bid that won the three-day May 2025 auction (seven bidders, opening bid $52 million) and was later topped
A bid that won the auction and then lost the sale, so filed as an offer. The auction began 14 May 2025; seven bidders took part from an opening bid of $52 million to $256 million. The same asset then sold for $305 million (23andme-ttam-research-institute-sale-order-305m), so the bundle moved 5.9 times from the opening bid to the sale.
Court record, In re 23andMe Holding Co., No. 25-40976 (Bankr. E.D. Mo.), ECF 908, Memorandum Opinion (27 Jun 2025)
$256 millionper bid for substantially all assets of one company (whole-business bundle)
Cite this
AIData.Broker, “Regeneron Pharmaceuticals in the AI training data market”, reviewed 13 Jun 2025. https://aidata.markets/companies/regeneron
Free to reuse under CC BY 4.0 if you credit AIData.Broker and link to this page. Each row names the publication that stated it, and words quoted from a source keep that source's own terms.